Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirinInt J Cardiol - Siller-Matula, JM; Delle-Karth, G; Christ, G (2013)
Epub ahead of print.